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Abstract
Background: The shell of Haliotis diversicolor, or shijueming (SJM), is a type of traditional Chinese medicine. The
SJM has appeared in historical records as early as the third and fourth centuries. Historical records have revealed
that SJM had mainly been used to treat eye diseases. After the Qing Dynasty (1757), records had emerged, detailing
the use of SJM for treating skin injuries, particularly for treating poorly managed ulcers or traumatic wounds.
Furthermore, in our anti-inflammation-screening system, SJM significantly inhibited the expression of pro-
inflammatory proteins. Previous studies have yet to adopt an animal model to verify the phenomenon and
described in the historical records regarding the efficacy of SJM in promoting wound healing. Besides, the
mechanism of wound healing effect of SJM is also not clear.
Methods: This study applied in vitro and in vivo models, tissue section analysis, and western blotting to evaluate
the effect of SJM on wound healing. The RAW 264.7 cells were used in anti-inflammatory activity assay and
phagocytic assay. Male Wistar rats were used to evaluate the effect of SJM on burn injury healing. A copper block
(2 × 2 cm, 150 g) preheated to 165 °C in a dry bath was used to contact the skin area for 10 s, thus creating a
full-thickness burn injury. The results were analyzed by hematoxylin and eosin staining, picrosirius red staining and
Western blotting.
Results: The results revealed that in the in vitro model, the presence of SJM decreased the inducible nitric oxide
synthase (iNOS) expression and enhanced the functions of macrophages. The results of the rat burn injury model
revealed that SJM decreased neutrophil infiltration, promoted wound healing, thus increasing the collagen I
content and promoting the expression of transforming growth factor-beta 1 (TGF-β1) protein. We speculate that
the effect and mechanism of SJM on promoting wound healing is related to macrophage activation. In the
inflammation phase, SJM alleviates inflammation by inhibiting iNOS expression and removing neutrophils through
phagocytosis. Furthermore, SJM induces the secretion of TGF-β1, converting collagen during the tissue remodeling
phase.
Conclusions: According to our review of relevant literature, this is the first study that applied an evidence-based
method to verify that SJM alleviates inflammation, enhances phagocytosis, and triggers wound healing after burn
injury. The study findings reveal that SJM provides a promising therapeutic option for treating burn injury.
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Background
Burn injuries, particularly those at the full-thickness
level, can develop into acute wounds that are difficult to
manage and heal [1]. Currently, standard treatment for
burn injuries involves using silver-containing antibiotics
to prevent infection [2]. Because silver ion is highly re-
active, it can bond with deoxyribonucleic acid, ribo-
nucleic acid, chloride ions, and other negatively charged
proteins [3]. Additionally, medical dressings are used to
maintain the hydration environment and air permeability
of a burn injury [4]. However, the aforementioned treat-
ment methods cannot be used to alleviate inflammation
or facilitate healing a burn injury. Previous studies have
indicated that silver sulfadiazine is toxic to keratinocytes
and fibroblasts, thus decreasing the healing rate of a
wound [5–8]. Consequently, scholars have suggested
that the use of silver-containing drugs should be avoided
when treating a wound [3]. Therefore, developing safe
drugs that promote wound healing is necessary.
Early studies have verified that macrophages facilitate
healing wounds through promoting angiogenesis and colla-
gen formation [9–12]. Laboratory rats with macrophage
depletion exhibit reductions in wound healing rate, collagen
formation, granulation tissue, angiogenesis, and secretion of
transforming growth factor-beta (TGF-β1; [13–15]), indi-
cating that macrophages facilitate healing wounds.
The shell of Haliotis diversicolor, or shijueming (SJM), is
a type of traditional Chinese medicine. The exact time
period in which this medicine was first used is debatable,
but this medicine has appeared in historical records as early
as the third and fourth centuries. Historical records have
revealed that SJM had mainly been used to treat eye dis-
eases. After the Qing Dynasty (1757), records had emerged,
detailing the use of SJM for treating skin injuries, particu-
larly for treating poorly managed ulcers or traumatic
wounds. In recent years, multiple scholars have analyzed
the pharmaceutical property of SJM using scientific
methods and techniques, thereby providing systematic,
scientized evidence supporting the use of this medicine.
Accordingly, the medical functions of SJM can be further
explored and verified.
Several studies have demonstrated the use of lipopolysac-
charide (LPS) challenged RAW 264.7 murine macrophage
cells, as a well-established model for in vitro anti-
inflammatory screening. Using this screening model, we
have successfully illustrate the several marine-derived sub-
stances can produce efficacious anti-inflammatory activity
in in vitro and in vivo models [16–19]. Thus, screening for
inhibitors of the pro-inflammatory mediators in marine
natural bioactive substances is a promising avenue for drug
development. Inflammation is the initial phase of wound
healing which the macrophages mainly take the role. Resi-
dent macrophages are activated and generate inflammatory
mediators such as nitric oxide (NO) to prevent infections
caused by the invasions of foreign pathogens. However,
prolonging the inflammatory response and delaying granu-
lation will cause delayed healing. Because excessive produc-
tion of NO also damages normal tissue [20, 21]. Thus, the
inhibition of inflammation is essential to wound treatment.
In our anti-inflammation-screening system, SJM signifi-
cantly inhibited the expression of pro-inflammatory pro-
teins. Moreover, decrease in oxidative stress may lead to
acceleration of the wound healing [22, 23]. A recent study
reported that a SJM solution significantly increased the
survival rate of human lens epithelial cells that are damaged
by hydrogen peroxide-induced oxidative stress [24]. There-
fore, based in the effect of protect oxidative damage and
anti-inflammation potential, SJM may has potential to en-
hance wound healing. This study applied in vitro and in
vivo models, tissue section analysis, and western blotting to
evaluate the effect of SJM on wound healing.
Methods
Haliotis diversicolor shell preparation
The shell of Haliotis diversicolor (Zheng-Der Chinese
herbal apothecary, Taipei, Taiwan) was placed in a metal
pot and calcined (300 °C for 15 min) until its surface
gloss was altered (Fig. 1). The shell was then cooled and
ground to fine powder (particle diameter < 75 μm). Be-
cause SJM is slightly soluble, the SJM powder was dis-
solved in a culture medium, and only the supernatant of
the medium was used in the in vitro experiment. Specif-
ically, the SJM powder was weighed and then loaded
into Dulbecco’s modified Eagle’s medium (DMEM, Invi-
trogen, Grand Island, NY, USA) containing 10% fetal bo-
vine serum. The resulting medium was evenly mixed,
sonicated for 15 min, and centrifuged for 10 min at
180 × g. The supernatant was acquired and loaded into a
new centrifuge tube and then centrifuged for 10 min at
400 × g. The resulting supernatant was filtered using
0.22 μm membrane to obtain a nonbacterial SJM solu-
tion. The solution was kept in a 4 °C refrigerator and
used as the culture medium. In this study, when 1 g of
SJM powder was added to 10 ml of cell growth medium,
the resulting supernatant solution was defined as having
a concentration of 10 mg/ml. Regarding the animal ex-
periment, the SJM powder was added to a mineral oil
(Macron, Center Valley, PA, USA) to prepare a high-
concentration 600 mg/mL solution (SJM-H) and a low-
concentration 200 mg/mL solution (SJM-L).
Cell culture and cell survival assay
The RAW 264.7 cells were grown in 1:1 DMEM (Invitro-
gen, Grand Island, NY, USA) containing 10% heat-
inactivated fetal bovine serum, penicillin G (100 U/ml),
and streptomycin (100 μg/ml). For the cell survival assay,
the cells were seeded in 96-well culture dishes (Corning,
NY, USA) at an initial density of 3000 cells/well. The SJM
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at suitable doses was added to cell culture. The cells were
cultured in DMEM medium within a 5% CO2 atmosphere
humidified incubator at 37 °C for 24 h. After 24 h incuba-
tion, 10% AlamarBlue (Invitrogen, Grand Island, NY,
USA) was aseptically added to measure cell viability. The
vehicle control group (without SJM) was defined as 100%.
The optical density (OD) of the supernatants were quanti-
fied at 570 nm, and the cell viabilities were analyzed ac-
cording to the following formula: Cell viability (%)
= (ODSJM – ODblank)/(ODcontrol – ODblank) × 100%.
Anti-inflammatory activity assay
10 × 106 RAW264.7 cells were cultured in a 10 cm culture
dish and administered with lipopolysaccharide (LPS,
0.01 μg/ml; Sigma, St. Louis, MO, USA). Specifically, 1, 2,
and 5 mg/mL SJM solutions were added into the culture
dish and followed by the addition of LPS. After 16 h of
LPS challenge, the protein expression of inducible nitric
oxide synthase (iNOS) was analyzed by Western blotting.
Phagocytic assay
A phagocytosis assay kit (Cayman Chemical, Ann Arbor,
MI, USA) was used to test the phagocytic capability of
macrophages. RAW 264.7 was cultured in a 24-well plate.
Specifically, 1, 2, and 5 mg/mL SJM solutions were
separately loaded into the selected wells. For every 1 ml of
culture medium, 100 μl of Latex Beads-Rabbit IgG-FITC
solution was loaded. The plate was cultured at 37 °C, and
the culture medium was replaced after 8 h. Finally, the
cultured cells were placed under a microscope to observe
the conditions of the fluorescently-labeled latex beads.
Neutral red phagocytic assay
RAW 264.7 cells were cultured in a 96-well plate. An
adherent culture method was applied, and the cells were
treated with 1, 2, and 5 mg/ml SJM solutions for 24 h.
The positive control group was loaded with a 0.5 μg/ml
LPS, followed by 100 μl of 0.075% neutral red solution
(Sigma, St. Louis, MO, USA) prepared with 1× phosphate
buffer saline (PBS). The plate was cultured at 37 °C for
1 h. The supernatant was removed, and the cultured cells
were washed with 1× PBS twice to remove residual neutral
red molecules that were not engulfed. Next, 100 μl of lys-
ate (1:1 alcohol to 0.01% acetic acid) was used to lyse the
cultured cells at room temperature for 1 h. Finally, an en-
zyme immunoassay analyzer (Epoch, BioTek Instruments,
Winooski, VT, USA) was used to measure the absorbance
value of the cells at 540 nm [25].
Burn injury creation and medical dressing
The animal experiment was approved by the Animal Care
and Use Committee of National Sun Yat-sen University
(Approval No. 10503) and the experiment complied with
the Guiding Principles in the Care and Use of Animals of
the American Physiology Society. Efforts were taken to
minimize animal discomfort and the number of animals
used for the experiment. Male Wistar rats (400–450 g)
were anesthetized with 2.5% isofurane. The hair on the
backs of the rats was shaved off. A rat burn injury model
was modified from previous studies [26–28]. Specifically,
the target skin area was tightly stretched to ensure a flat
contact surface. A copper block (2 × 2 cm, 150 g) pre-
heated to 165 °C in a dry bath was used to contact the skin
area for 10 s, thus creating a full-thickness burn injury.
During the process of burn injury creation, the copper
block was lightly shaken while pressed onto the skin sur-
face to create a complete, square-shape wound. No add-
itional pressure was exerted on the copper block to ensure
that each burn injury was created using the similar pres-
sure. The injured rats were randomly assigned into the
following groups:
Control: no burn injury or medicine was given.
Burn + untreated: burnt but no medicine was given.
Burn + vehicle: burnt and then smeared with 0.2 ml of
mineral oil.
Burn + SJM-H: burnt and then treated with 0.2 ml of
600 mg/ml SJM solution daily.
Burn + SJM-L: burnt and then treated with 0.2 ml of
200 mg/ml SJM solution daily.
Fig. 1 The SJM before (a) and after (b) calcined. SJM was placed in
a metal pot and calcined, note the surface gloss was altered after
calcined. Scale = 1 cm
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The identical dosages of medicine were applied to the
rats during the same time each day. Before each dressing,
the wound was cleaned with a sterilized saline solution to
remove residual medicine and foreign matters. A sterilized
cotton swab was used to dry the saline solution, and then
the medicine was evenly smeared onto the wound. Every
two days, the rats were anesthetized and then placed on a
copy stand. The rats were photographed under identical
conditions using a digital camera (Coolpix P6000, Nikon,
Japan). SPOT software (Diagnostic Instruments, Inc.,
Sterling Heights, MI, USA) was used to examine the area
of each skin wound.
Histopathological analysis
For the histopathological examination, the rats were sacri-
ficed after perfusion with PBS and 4% paraformaldehyde as
described previously [29, 30], and the skin was removed
and fixed in 4% paraformaldehyde for 3 days. The speci-
mens were dehydrated in a graded series of alcohol by ro-
tary tissue processor (Sakura Finetek, Japan) and embedded
with paraffin, and 2-μm sections were prepared for
hematoxylin and eosin staining to assess the general and
pathological changes. The sections were examination by
light microscopy (DM 6000B, Leica Inc. Wetzlar, Germany)
with a microscope digital image output system (idea SPOT,
Diagnostic Instruments Inc., Steriling Heights, MI, USA).
Histological sections stained in picrosirius red (picrosirius
red stain kit, Polysciences, Warrington, PA, USA) and ana-
lyzed under polarized light were used to analysis of the col-
lagen deposition after burn injury. Collagen fibers were
analyzed according to their color which collagen I and
collagen III respectively appear red and green.
Western blotting
After 16-h incubation, the cells were washed with ice-cold
PBS, lysed in ice-cold lysis buffer (50 mM Tris, pH 7.5,
150 mM NaCl, 1% Triton X-100, 100 mg/ml phenylmethyl-
sulphonyl fluoride, 1 mg/ml aprotinin), and then centri-
fuged at 20 000 × g for 30 min at 4 °C. The supernatant was
decanted from the pellet and retained for Western blot.
Protein concentrations were determined using the DC pro-
tein assay kit (Bio-Rad, Hercules, CA, USA). The animals
were sacrificed at 7 days after injury, the skin was collected
and washed with ice-cold PBS and homogenized in lysis
buffer using a Polytron homogenizer (Precellys®24 tissue
homogenizer; Bertin Technologies, Rockville, MD, USA) at
4 °C. Samples were then ultracentrifuged for 1 h at 4 °C,
and the supernatant was measured using a DC protein
assay kit (Bio-Rad, Hercules, CA, USA).
The samples then electrophoresed through a tricine SDS-
polyacrylamide gel and transferred to a polyvinylidene
difluoride membrane (PVDF membrane; Immobilon-P,
Millipore, 0.45-μM pore size). After blocking for 1 h at
room temperature with 5% non-fat milk in Tris-buffered
saline (TTBS; 137 mM NaCl, 20 mM Tris–HCl, 0.1%
Tween-20®, pH 7.4), the PVDF membrane was then incu-
bated overnight at 4 °C with primary antibodies: rabbit
polyclonal antibody against TGF-β1 (1:1000; Cat. Ab92486;
Abcam, Cambridge, MA, USA). The immunoreactive
bands were visualized by enhanced chemiluminescence
(ECL kit; Millipore, Bedford, MA) and by the UVP Bio-
Chemi Imaging System; and relative densitometric quantifi-
cation was performed using LabWorks 4.0 software (UVP,
Upland, CA). Monoclonal antibodies against β-actin were
used as the internal loading control. The quantification data
were expressed as a ratio of the protein of interest to β-
actin. The relative variations between the bands of the vari-
ous treatment samples and of the control group were calcu-
lated using the same image.
Statistical analysis
All data are presented as the mean ± SEM. For the immu-
noreactivity data, the intensity of each test band is
expressed as the integrated optical density (IOD), calculated
with respect to the average optical density of the corre-
sponding control (LPS or control) band. For statistical ana-
lysis, all of the data were analyzed by a one-way analysis of
variance (ANOVA), followed by the Duncan’s method for
multiple comparisons (Systat Software, San Jose, CA, USA).
We defined a significant difference as p < 0.05.
Results
Promotion of macrophage proliferation and phagocytosis
The RAW 264.7 cells were treated with SJM solutions of
various concentrations for 24 h. The survival rate of the
control group was 100% (±1.2%). The survival rates of the
cells treated with 0.1, 1, 2, and 5 mg/ml of SJM solutions
were 96.7% (±1.2%), 108.8% (±2.1%), 113.5% (±1.3%) and
124.2% (±1.3%), respectively (Fig. 2). Particularly, the sur-
vival rates of the cells treated with 1–5 mg/ml SJM solu-
tions were significantly higher than those of the control
group, indicating that SJM promotes macrophage prolifer-
ation. Next, the effect of SJM on the phagocytic capability
of macrophages was examined. Compared with the con-
trol group, the RAW 264.7 cells treated with SJM for 8 h
exhibited enhanced capability in engulfing fluorescent
beads (Fig. 3a). The neutral red phagocytic assay was also
applied to determine the effect of SJM treatment on the
phagocytic capability of macrophages. The results revealed
that after treatment with 1, 2, and 5 mg/ml SJM solutions
for 24 h, the macrophage cells exhibited absorbance values
of 0.492 (±0.032), 0.520 (±0.035), and 0.556 (±0.013), re-
spectively, at 540 nm. The control group and positive con-
trol group (treated with LPS) exhibited absorbance values
of 0.377 (±0.002) and 0.463 (±0.018), respectively (Fig. 3b).
The statistical analysis results showed that the absorbance
values of the SJM treated group and positive control
group were significantly higher than those of the control
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group. Therefore, SJM enhanced the phagocytic capability
of macrophages.
Anti-inflammation effect of SJM
Wound healing in the skin involves an inflammation
stage to remove foreign microorganisms and dead
cells. However, an extensive, chronic inflammation
decreases the healing rate of a wound and even in-
creases the probability of scarring. Therefore, this
study applied LPS to induce macrophage inflamma-
tion and generate an inflammation factor, iNOS. The
results revealed that compared with the control
group, the cells treated with LSP exhibited an in-
creased expression of iNOS, whereas the expression
of iNOS was inhibited in those treated with 1, 2, and
5 mg/ml SJM (Fig. 3c).
Effect of SJM on healing rate of burn injury
Figure 4a illustrates the images of the burn injuries after 0,
4, 7, 14, 21, and 28 days. The results revealed that although
the wound of each group gradually healed with time, the
wounds of the burn + SJM groups had begun to heal
noticeably after 14 days. After 28 days, the wound of the
Fig. 2 Effect of SJM on the survival rate of mice macrophage RAW
264.7. The survival rates of the groups treated with 1–5 mg/ml SJM
increased significantly, indicating that SJM promotes macrophage
proliferation. *denotes p < 0.05 compared with the control group
Fig. 3 Effect of SJM on RAW 264.7 phagocytic capability and in vitro anti-inflammation. a The Cayman phagocytosis assay kit was applied to treat the
cells with SJM for 8 h. Observing the cells under a microscope revealed that compared with the vehicle group, the SJM-treated cells exhibited enhanced
ability in engulfing the fluorescent beads. b The neutral red experiment was conducted to observe the effect of SJM on the phagocytic capability of
RAW 264.7. The statistical results showed that the absorbance values of the RAW 264.7 SJM- and LPS-treated cells were significantly higher than that of
the control group, indicating that SJM enhances the phagocytic ability of macrophages. cThe RAW 264.7 cells were treated with LPS and SJM for 16 h,
and then western blotting was applied to detect the expression of iNOS in these cells. The results revealed that LSP induced RAW 264.7 to synthesize
inflammation factor iNOS. However, SJM significantly inhibited LPS from inducing the synthesis of iNOS proteins. # denotes p < 0.05 compared with the
control group and * denotes p< 0.05 compared with the LPS group; scale = 100 μm
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burn + SJM-L group was mostly healed. Calculating
the wound areas of different groups (Fig. 4b) revealed
that the wound healing rates of the vehicle and burn
groups did not differ, whereas those of the burn +
SJM-H and burn + SJM-L groups were higher than
that of the burn + vehicle group. By transforming the
data to the area under the wound area–time curve
(AUC), compared to the burn + vehicle group, animals
receiving SJM-L and SJM-H treatment showed signifi-
cant improvement in wound healing (Fig. 4c).
Effect of SJM on the histopathology of burn injury
Histopatholgical staining analysis was applied to exam-
ine the effect of SJM on wound tissues. After 3, 7, 14,
and 28 days of burn treatment, the rats were sacrificed
to obtain their skin samples, which were then stained
using hematoxylin and erosin (Fig. 5a). Observing these
images revealed that 3 days after injury, noticeable hair
follicle shedding and epidermis thickening were ob-
served in the burn + untreated, burn + vehicle, burn +
SJM-H, and burn + SJM-L group, the number of cells
Fig. 4 Effect of SJM on the burn injury appearances of the rats. The 165 °C copper block was used to create full-thickness burn injuries on the rats, and
the wounds were photographed every two days. The wounds were continually observed for 28 days. (The images illustrate the wound appearances
after 0, 4, 7, 14, 21, and 28 days. b The curves represent the wound area of each group (displayed as percentage value) versus number of days. The
results revealed that the wound healing areas of the burn + vehicle and burn + untreated groups differed nonsignificantly, and the wound healing
rates of burn + SJM groups were significantly higher than that of the burn + vehicle group. c The area under the wound area–time curve is shown for
the burn + SJM-L and burn + SJM-H-treated groups, which exhibited significant improvement compared to the burn + vehicle group. Scale = 1 cm *
denotes p < 0.05 compared with the burn + untreated group and # denotes p < 0.05 compared with the burn + vehicle group
Chen et al. BMC Complementary and Alternative Medicine  (2016) 16:487 Page 6 of 12
near the epidermis was considerably reduced. Seven days
after injury, the fair follicles of each group mostly disap-
peared, but the stratum corneum did not shed. The dermal
collagen fibers were fused; hence, the shapes of the collagen
fibers were not observable. In the dermis of the vehicle
group, neutrophil infiltration was observed, indicating that
the wound was still inflamed (Fig. 5b). Epidermal curst was
observed in the burn + SJM-L group, the epidermis of
which noticeably thickened, and the proliferation of colla-
gen fibers was also observed. The burn + SJM-H group also
exhibited proliferation of collagen fibers and a noticeable
decrease in neutrophil infiltration. Fourteen days after in-
jury, the epidermal layers of the injury and vehicle groups
had not formed yet, and the hair follicles did not appear.
Moreover, macrophage and neutrophil infiltrations were
still observed in these two groups. By contrast, the epider-
mis of the burn + SJM-L group had begun to form, and a
large amount of collagen fibers appeared. The burn + SJM-
H group formed a complete epidermal layer, and a large
amount of fibroblasts appeared. Twenty-eight days after in-
jury, the burn + untreated group still did not form a
complete epidermal structure, and granulation tissues were
still observable. The burn + vehicle group formed a thick,
uneven epidermal layer, but hair follicles did not appear yet.
The burn + SJM-L and burn + SJM-H groups not only
formed complete epidermal layers but also high amounts of
complete hair follicles. Similar to those of the control
group, the fibers of these groups were thick and neatly ar-
ranged, and no inflamed cells were observed. The afore-
mentioned results revealed that after burn injury, although
the wounds of the burn + untreated and burn + vehicle
groups gradually decreased, the results of the tissue staining
analysis revealed that the wounds were still inflamed, and
an extensive period was required to form new epidermal
layers and hair follicles. By contrast, the burn + SJM groups
had begun to form epidermal layers after 14 days, and the
granulation tissues developed more quickly and completely
compared with those of the burn + untreated and burn +
vehicle groups. After 28 days, the epidermal layers and hair
follicles of the burn + SJM groups completely developed.
Overall, SJM facilitates healing burnt tissues.
Effect of SJM on increasing collagen and TGF-β1 contents
in burn injury
Previous studies have indicated that the collagen content
of a wound affects the proliferation and migration of the
Fig. 5 Histological evaluation of burn wound healing effect of SJM. a Paraffin wax tissue sections were stained with hematoxylin and erosin stain to
observe the tissues of the burn wounds. Three days after the injury, hair follicle shedding and epidermis thickening were observed in each group, and the
number of cells near the epidermis markedly decrased. After 7 days, the hair follicles of each group disappeared. Scarring was obervsed in the burn + SJM-
L group, and the burn + SJM-H group exhibited collagen proliferation. After 14 days, the burn + untreated and burn + vehicle groups did not form the
epidermis, whereas that of the burn + SJM-L group had begun to form, and a large amount of collagen was observed in this group. The burn + SJM-H
group had already devleoped a complete epidermal layer along with a high deposition of collagen fibers. After 28 days, the burn + untreated group
exhibited an incomplete epidermal structure, and granulation tissues were still observed. The burn + vehicle group had already grown a thicker epidermis
compared with the injury group, but its hair follicles did not appear. The burn + SJM-L and burn + SJM-H groups not only exhibited complete epidermis
but also large amounts of hair follicles, and their tissue fibers were neatly arranged. b Observing the magnified image of the corium layer revealed that
after 7 and 14 days, the SJM-treated groups exhibited reduced neutrophil infiltration. Scales for (a) and (b) are 500 μm and 50 μm, respectively. EP, epithelial
layer. ★ indicates hair follicle;▲ indicates neutrophil infiltration; arrow indicates collagen fiber
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epidermal cells as well as the robustness of the wound.
Therefore, the present study applied picrosirius red
staining and a polarized light microscope, under which
collagen I and collagen III respectively appear red and
green. Next, ImageJ was used to quantified the red and
green pixels in the images of the wounds (Fig. 6). The
Fig. 6 Determining the collagen contents of the SJM and vehicle groups using sirius red stain analysis. The paraffin wax tissue sections were
stained with sirius red; hence, under a polarized light, collagen I and III appeared red and green, respectively. Fourteen days after burn injury, the
collagen I content of each group significantly increased, with the burn + SJM groups having a higher content than did the burn + vehicle group.
Conversely, the collagen III contents of the burn + SJM groups were significantly less than that of the burn + vehicle group. Scale = 500 μm;
* denotes p < 0.05 compared with the control group and # denotes p < 0.05 compared with the burn + vehicle group
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results revealed that after 14 days, the collagen I content
of each group significantly increased, and the burn +
SJM groups exhibited significantly greater collagen I de-
position than did the burn + vehicle group. Conversely,
the collagen III content of the burn + SJM groups were
significantly less than that of the burn + vehicle group.
To further analyze the potential mechanisms through
which SJM facilitates healing wounds and increasing col-
lagen content, we collected skin samples on the seventh
day after burn injury, and western blotting was applied to
investigate the TGF-β1 content (Fig. 7). The results re-
vealed that on the seventh day, the TGF-β1 content of the
burn + SJM groups significantly increased compared with
that of the control group. Compared with the burn + un-
treated and burn + vehicle groups, the burn + SJM groups
demonstrated significantly increased TGF-β1 content.
Discussion
This study applied in vitro and in vivo models to investi-
gate the effect of SJM on wound healing. The results re-
vealed that in the in vitro model, the presence of SJM
decreased the iNOS expression and enhanced the func-
tions of macrophages. The results of the rat burn injury
model revealed that SJM decreased neutrophil infiltration,
promoted wound healing, thus increasing the collagen I
content and promoting the expression of TGF-β1 protein.
The healing process of a burn injury is generally divided
into three sequential but interrelated phases, namely the in-
flammation phase, tissue formation phase (proliferative
phase), and tissue remodeling phase [31]. Immediately fol-
lowing a burn injury is the inflammation phase, during
which the injured blood vessels constrict within few mi-
nutes, and thrombocytes gather at the cortices of the in-
jured blood vessels to prevent blood loss [32]. The injured
area exhibits typical inflammation symptoms: redness,
swelling, hotness, and pain. During the inflammation phase,
thrombocytes secrete growth factors that signal leukocytes
to enter the injured area. Neutrophils are the first to enter
the injured area, followed by monocytes and lymphocytes
[33]. Monocytes mainly function as the antibiotic mechan-
ism of an organism and secrets a protease to remove
denatured extracellular matrices. In the blood clots, throm-
bocytes secretes TGF-β, transforming monocytes in the
injured area into macrophages, which remove cellular re-
siduals in the injured area and secrete various types of cyto-
kine including fibroblast growth factors (FGFs), TGF-β,
platelet-derived growth factors (PDGFs), and epidermal
growth factors (EGFs; [34]). These cytokines also trigger
the mechanism of granulation tissue formation.
Inflammation reactions induced by a burn injury can
prevent infections caused by the invasions of foreign mi-
croorganisms. However, inflammation also damages
nearby tissues [35]. Therefore, antiinflammation is also es-
sential to wound treatment. Although the inflammation
phase does not account for the majority of the overall
wound healing process, previous studies have verified that
cell activations and cytokine secretions during this phase
can affect the final wound condition [36, 37]. The in vitro
model of the present study revealed that SJM decreased
the expression of iNOS induced by LPS. Moreover, ob-
serving the Day-7 and Day-14 tissue sections acquired
from the animal model showed that compared with the
burn + vehicle group, the burn + SJM groups exhibited de-
creased amounts of inflamed cells, indicating that SJM al-
leviates inflammations during wound healing. In the
inflammation phase, macrophages mainly function to re-
move neutrophils. Specifically, macrophages first induce
the apoptosis of neutrophils, which are then removed
through phagocytosis [38, 39] to prevent inflammation
from spreading. Afterward, some macrophages also
undergo apoptosis, and the remaining macrophages con-
tinue to remain in the injured area and affect subsequent
wound healing processes including collagen formation,
angiogenesis, and reepithelialization [40]. The in vitro
experiment revealed that SJM enhanced the phagocytic
capability of macrophages; therefore, this study infers that
the antiinflammation mechanism of SJM is related to
macrophage function and reduced iNOS expression.
After the inflammation phase follows the proliferative
phase, during which cells secrete cytokines that are then
Fig. 7 Effect of SJM on the TGF-β1 expression in the rats. After
7 days, the rats were sacrificed to collect their skin samples, and
western blotting was used to examine the expression of TGF-β1. The
results revealed that SJM enhanced the burn-induced upregulation
of TGF-β1. * denotes p < 0.05 compared with the control group and
# denotes p < 0.05 compared with the burn + vehicle group
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used by newly formed skins. Reepithelialization and angio-
genesis are the most essential processes in the proliferative
phase. During the process of wound healing, keratinocytes,
fibroblasts, thrombocytes, and macrophages secrete
TGF-β1 [41–44]. This protein exhibits a wide range
of effects, influencing all types of cells involved in a
wound healing process. Moreover, TGF-β1 is crucial
to reepithelialization [45]. Mirza et al. [14] specifically
ablate macrophages during wound healing and con-
firmed that macrophage ablation drastically slows the
rate of wound healing, further verifying that TGF-β1
secreted by macrophages is essential to wound heal-
ing. Furthermore, the in vitro and in vivo experiments
verified that TGF-β1 enhances the migration of kera-
tinocytes [46, 47] and secretion of vascular endothelia
growth factors (VEGFs) to promote angiogenesis [48].
Angiogenesis is mainly promoted through the TGF-β1,
FGFs, and VEGFs secreted by macrophages [9–11].
Previous studies have confirmed that drug-induced activa-
tion and proliferation of macrophages enhance reepithe-
lialization and wound strength [49, 50]. Using western
blotting to examine the skin samples on the seventh day
of burn injury revealed that SJM promoted TGF-β1 ex-
pression. Therefore, the effectiveness of SJM in promoting
wound healing and epidermis formation should be related
to how it activates macrophages to secrete TGF-β1.
The tissue remodeling phase is the final phase of
wound healing and mainly features the dynamic balance
between collagen formation and lysis. Collagen III fibers,
which were formed during the initial wound healing
process, are replaced with collagen I fibers. Moreover,
collagen fibers are arranged into a desirable shape. The
process in which the arrangement of collagen fibers
gradually increases the wound strength [51] is called
scarring, which is promoted by TGF-β1 and PDGFs [52,
53]. Particularly, TGF-β1 inhibits metalloproteinases,
namely MMP-1, MMP-3, and MMP-9, and promotes
the biosynthesis of metalloproteinase tissue inhibitor
TIMP-1, thus inhibiting collagen degradation [54, 55].
Therefore, increasing the content of TGF-β1 facili-
tates wound healing processes, particularly the forma-
tion of collagen. The present study verified that seven
days after burn injury, SJM promoted the expression
of TGF-β1. Moreover, the sirius red staining experi-
ment revealed that SJM facilitates converting collagen
III to collagen I.
On the basis of previous studies, the chemical constitu-
ents of the shell of Haliotis diversicolor comprised Ba, Co,
Cr, Cu, Fe, Mg, Mn, Na, P, Pb, Si, Sr, Ti, V, Zn, Ca, and
CaCO3 and glutamic acid, aspartic acid, alanine, serine,
and glycine [56, 57]. However, these chemicals may not be
the major compounds that contribute to wound healing.
Additional studies are warranted to confirm the major
compounds that are involved in wound healing.
Conclusions
According to the aforementioned results, we speculate
that the effect and mechanism of SJM on promoting
wound healing is related to macrophage activation. In the
inflammation phase, SJM alleviates inflammation by inhi-
biting iNOS expression and removing neutrophils through
phagocytosis. Furthermore, SJM induces the secretion of
TGF-β1, converting collagen during the tissue remodeling
phase. This study was the first to apply an evidence-based
method to verify that SJM alleviates inflammation, en-
hances phagocytosis, and triggers wound healing. More-
over, SJM activates macrophages, which may promoting
the secretion of growth factors. Subsequent studies can
further examine whether SJM promotes growth factors.
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